EXTON, Penn. and SAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex ...

MALVERN, Pa., March 04, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospitals and other acute care ...

President Donald Trump in March said he was considering suing drug companies fueling the opioid crisis — and Congress will allocate $6 billion in new funding over the next two years to advance the ...

With manufacturing operations already locked up in Georgia, Recro Pharma is taking its CDMO ambitions coast-to-coast. Recro has dished out nearly $50 million to acquire CDMO peer Irisys. The deal for ...

At the time of writing, our data shows that Recro Pharma, Inc. has a market capitalization of US$47m, and reported total annual CEO compensation of US$4.6m for the year to December 2019. We note ...

MALVERN, Pa., April 03, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company with a high-performing contract development and manufacturing ...

Company Owns and Operates Over 120,000 Square Feet of U.S. cGMP and DEA-Licensed Contract Development and Manufacturing Facilities Focused on Creating Oral, Solid Dose Drug Products Long, Proven Track ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The two companies received a total of $7.7 million in PPP ...

Georgia-based CDMO Recro Pharma is rebranding itself as Societal CDMO in an effort to better communicate its services in the wake of a $50 million deal last summer for San Diego-based contract ...

Good morning, and welcome to Recro's third-quarter 2020 financial results conference call. [Operator instructions] As a reminder, this conference call is being recorded at the company's request. I ...

Six Recent Hires Provide Broader Coverage and Expanded Capabilities in the Areas of Sales and Marketing Significant Traction Already Achieved in First Months of 2021 MALVERN, Pa., April 05, 2021 ...

Recro Pharma ($REPH) had to dial down its asking price and amp up its offering, but the Malvern, PA, biotech managed to go public at last, grossing $30 million to ...